The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-chloro-N-(4-(N-hydroxysulfamoyl)phenethyl)-2-methoxybenzamide ID: ALA4583133
Cas Number: 2112809-98-8
PubChem CID: 134600183
Product Number: J648756, Order Now?
Max Phase: Preclinical
Molecular Formula: C16H17ClN2O5S
Molecular Weight: 384.84
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NO)cc1
Standard InChI: InChI=1S/C16H17ClN2O5S/c1-24-15-7-4-12(17)10-14(15)16(20)18-9-8-11-2-5-13(6-3-11)25(22,23)19-21/h2-7,10,19,21H,8-9H2,1H3,(H,18,20)
Standard InChI Key: KQRQPMUPYDOTCA-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 26 0 0 0 0 0 0 0 0999 V2000
13.9748 -5.9721 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.3875 -6.6820 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.7959 -5.9696 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.0969 -7.0912 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.6815 -7.0901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9785 -6.6818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2730 -7.0893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2730 -7.9056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9844 -8.3128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6870 -7.9031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5660 -8.3155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0972 -7.9084 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.8575 -7.9082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1506 -8.3181 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4421 -7.9108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7352 -8.3207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4406 -7.0936 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0283 -7.9089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3219 -8.3181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3229 -9.1362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0364 -9.5433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7399 -9.1318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4500 -9.5363 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4547 -10.3535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6136 -7.9105 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 2 1 0
2 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
8 11 1 0
4 12 1 0
11 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
15 17 2 0
16 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 16 1 0
22 23 1 0
23 24 1 0
19 25 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 384.84Molecular Weight (Monoisotopic): 384.0547AlogP: 1.99#Rotatable Bonds: 7Polar Surface Area: 104.73Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.20CX Basic pKa: ┄CX LogP: 2.11CX LogD: 2.10Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.63Np Likeness Score: -1.13
References 1. Zhang X, Xu A, Lv J, Zhang Q, Ran Y, Wei C, Wu J.. (2020) Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases., 185 [PMID:31699536 ] [10.1016/j.ejmech.2019.111822 ] 2. Zhang C, Yue H, Sun P, Hua L, Liang S, Ou Y, Wu D, Wu X, Chen H, Hao Y, Hu W, Yang Z.. (2021) Discovery of chalcone analogues as novel NLRP3 inflammasome inhibitors with potent anti-inflammation activities., 219 [PMID:33845232 ] [10.1016/j.ejmech.2021.113417 ]